Skip to main content
Australia Edition
Sunday, 19 September 2021

Monday 9/13 Insider Buying Report: BHG, IMNM

Duration: 00:54s 0 shares 4 views

Monday 9/13 Insider Buying Report: BHG, IMNM
Monday 9/13 Insider Buying Report: BHG, IMNM

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

So let's look at two noteworthy recent insider buys.

On Wednesday, Bright Health Group's, Manuel Kadre, made a $959,000 purchase of BHG, buying 100,000 shares at a cost of $9.59 each.

Kadre was up about 6.5% on the buy at the high point of today's trading session, with BHG trading as high as $10.21 in trading on Monday.

Bright Health Group is trading up about 4.5% on the day Monday.

Before this latest buy, Kadre bought BHG at 3 other times during the past twelve months, for a total cost of $692,025 at an average of $8.65 per share.

And at Immunome, there was insider buying on Friday, by Director Michael Rapp who bought 45,950 shares for a cost of $18.07 each, for a trade totaling $830,449.

Before this latest buy, Rapp bought IMNM on 3 other occasions during the past twelve months, for a total cost of $2.97M at an average of $15.59 per share.

Immunome is trading up about 5.9% on the day Monday.

So far Rapp is in the green, up about 10.4% on their purchase based on today's trading high of $19.95.

Related news coverage

Advertisement

More coverage